Yestar Healthcare Holdings Company Limited (HKG:2393)
Hong Kong · Delayed Price · Currency is HKD 0.0650
-0.0030 (-4.41%)
Oct 22, 2026, 3:33 PM HKT
HKG:2393 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,349 | 1,490 | 2,410 | 2,913 | 2,805 | 4,931 |
Revenue Growth | -9.46% | -38.17% | -17.26% | 3.86% | -43.12% | 20.06% |
Gross Profit Gross Profit Growth | 277.93 | 266.86 | 399.2 | 512.78 | 397.55 | 848.7 |
Operating Income Operating Income Growth | 15.69 | 12.21 | 60.63 | 171.04 | -106.83 | 184.37 |
Net Income Net Income Growth | -83.96 | -75.03 | 921.61 | -13.89 | -992.23 | 3.33 |
Earnings Per Share EPS Growth | -0.04 | -0.03 | 0.40 | -0.01 | -0.43 | 0.00 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Imaging Printing Products Imaging Printing Products Growth | 217.75 | 168.36 | 317.9 | 321.78 | 359.92 | 1,027 |
Medical Products and Equipment Medical Products and Equipment Growth | 1,131 | 1,322 | 2,577 | 2,784 | 2,641 | 6,155 |
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth | - | - | -484.88 | -192.92 | -196.45 | -2,251 |
Total Total Growth | 1,349 | 1,490 | 2,410 | 2,913 | 2,805 | 4,931 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 194.44 | 256.61 | 121.06 | 251.56 | 418.15 | 751.77 |
Total Debt Total Debt Growth | 202.51 | 210.96 | 316.9 | 1,628 | 1,897 | 1,790 |
Net Cash (Debt) Net Cash Growth | -8.07 | 45.65 | -195.84 | -1,377 | -1,479 | -1,039 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | 0.02 | -0.08 | -0.59 | -0.63 | -0.44 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 147.64 | 311.32 | 12.72 | 385.87 | -91.73 | 715.22 |
Capital Expenditures CapEx Growth | -61.39 | -21.91 | -39.17 | -93.33 | -23.85 | -49.67 |
Free Cash Flow Free Cash Flow Growth | 86.25 | 289.4 | -26.45 | 292.54 | -115.58 | 665.55 |
Free Cash Flow Growth | -70.20% | - | - | - | - | 12.44% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 20.60% | 17.91% | 16.56% | 17.61% | 14.17% | 17.21% |
Operating Margin | 1.16% | 0.82% | 2.52% | 5.87% | -3.81% | 3.74% |
Pretax Margin | -4.20% | -3.48% | 38.58% | 1.41% | -17.29% | 1.22% |
Profit Margin | -6.22% | -5.04% | 38.24% | -0.48% | -35.38% | 0.07% |
FCF Margin | 6.39% | 19.42% | -1.10% | 10.04% | -4.12% | 13.50% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 0.15 | - | - | 656.57 |
Forward PE | - | 49.75 | 49.75 | 49.75 | 49.75 | 10.71 |
P/FCF Ratio | 1.52 | 0.73 | - | 0.33 | - | 3.28 |
PS Ratio | 0.10 | 0.14 | 0.06 | 0.03 | 0.24 | 0.44 |